Last updated: Oct 12, 2026, 12:00 AM

Audax Renovables S.A. Exchange (MC, EUR)

ADX.MC

1.08
-0.01 (-0.92%)
UtilitiesUtilities - Renewable
Invest Today
Invest Today
1 year return (CAGR)
-19.04%
3 year return (CAGR)
-1.73%
5 year return (CAGR)
-4.94%
10 year return (CAGR)
8.91%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
480.39M
Price/Sales
0.26
Ent value
1.36B
Price/Book
2.03
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-1.24%
Trailing P/E
40.21
PEG
-
Forward P/E
9.82
EPS growth
-6.20%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open1.09
Daily high1.10
Daily low1.07
Daily Volume169K
All-time high9.72
1y analyst estimate2.35
Beta1.15
EPS (TTM)0.03
Dividend per share0.00
Ex-div date1 Jul 2026
Next earnings date28 Feb 2026

Ready to capitalize on Audax Renovables S.A.'s growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
ADX.MCS&P500
Current price drop from All-time high-88.89%-0.66%
Highest price drop-97.22%-56.47%
Date of highest drop25 Apr 20139 Mar 2009
Avg drop from high-80.33%-10.66%
Avg time to new high70 days12 days
Max time to new high4912 days1805 days
News
Energy markets are back in the spotlight as Brent and WTI react to Middle East risk, Russia’s shifting fuel exports and fresh forecasts from Goldman Sachs that keep supply worries alive. Price swings ...
October 12, 2026
PARIS, October 12, 2026--Regulatory News: Gecina (Paris:GFC):
October 12, 2026
Ramsay Générale de Santé has spent the past few years under pressure, yet the shares have climbed modestly over the past year, which puts a fresh spotlight on what investors are paying for its sales t...
October 10, 2026
Ramsay Générale de Santé (ENXTPA:GDS) has called a board meeting for 6 October 2026 to review the auditors’ certification report on its consolidated accounts, a routine governance step that remains im...
October 10, 2026
Melexis has delivered a mixed share price record over recent years, which raises a direct question for anyone looking at the stock today. Is the current market valuation really supported by the cash f...
October 9, 2026
Oncology stocks are gaining relevance as cancer care evolves, with Pfizer, Merit Medical Systems and Abbott advancing treatments, diagnostics and screening technologies.
October 9, 2026
Suominen Corporation’s stock exchange release on October 9, 2026, at 11:00 a.m. (EEST) Suominen Corporation will publish its financial reports in 2027 as follows: March 2, 2027 – Financial Statements ...
October 9, 2026
Investing.com -- Barclays downgraded Ryanair and Norwegian Air Shuttle to Equal Weight from Overweight, saying persistently high fuel prices threaten fourth-quarter and 2027 profits across European ai...
October 9, 2026